SCHEMBL4650386

SCHEMBL4650386

CC(=O)c1cc(Cl)ccc1OCC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.64
▸ G6PD P11413 1/20 0.64
▸ TRPM4 Q8TD43 2/20 0.63
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ KDM4E B2RXH2 2/20 0.62
▸ ALDH1A1 P00352 1/20 0.62
▸ NPC1 O15118 2/20 0.59
▸ RAB9A P51151 2/20 0.59
▸ MAPT P10636 4/20 0.57
▸ GAA P10253 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ TP53 P04637 2/20 0.56
▸ L3MBTL1 Q9Y468 4/20 0.56
▸ HTT P42858 2/20 0.56
▸ CTDSP1 Q9GZU7 1/20 0.55
▸ NOD2 Q9HC29 1/20 0.55
▸ HCAR2 Q8TDS4 1/20 0.55
▸ CASP3 P42574 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4649772 0.91 TRPM4 (0.66) POLBG6PDTRPM4MEN1KMT2A
SCHEMBL4651368 0.89 POLB (0.62) POLBG6PDTRPM4MEN1KMT2A
SCHEMBL4650573 0.87 HCAR2 (0.56) POLBTRPM4MEN1KMT2AKDM4E
SCHEMBL4908222 0.87 MAPT (0.71) POLBG6PDTRPM4MEN1KMT2A
SCHEMBL4293544 0.87 MEN1 (0.79) POLBG6PDTRPM4MEN1KMT2A
SCHEMBL4650292 0.86 HCAR2 (0.55) POLBG6PDTRPM4MEN1KMT2A
SCHEMBL27727540 0.85 MEN1 (0.62) TRPM4MEN1KMT2AKDM4EALDH1A1
SCHEMBL4650699 0.85 KDM4E (0.55) POLBG6PDTRPM4MEN1KMT2A
SCHEMBL4910731 0.85 TRPM4 (0.64) POLBG6PDTRPM4MEN1KMT2A
SCHEMBL4650465 0.84 HCAR2 (0.56) POLBG6PDTRPM4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101336236-A Anthranilic acid derivatives useful in treating infection with hepatitis c virus WYETH CORP (US) 2008-12-31 — — CN claimed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 — — EP claimed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 — — WO claimed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 — — EP disclosed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 — — WO disclosed
Send feedback